The Board of Directors of the Galenica Group has designated Stefan Schulz (pictured), currently CEO of Vifor Fresenius Medical Care Renal Pharma (VFMCRP), as Chief Operating Officer (COO) and President of the Executive Committee of Vifor Pharma.
Stefan has been CEO of VFMCRP, the common company of Galenica and Fresenius Medical Care, since 2014. Prior to that he held various senior positions as Executive Vice President Sales & Marketing and President & General Manager of Fresenius HemoCare’s Adsorber Technology Business Unit, Germany; President of Fresenius HemoCare, USA; and Senior Vice President Business Development at Fresenius Medical Care North America, Germany and USA.
The Board of Directors has also appointed Felix Burkhard as CFO of the Galenical Group. Felix joined the Galenica Group in 1996 and has held various positions over the years, initially as Corporate Controller. From 2000 he was charged with implementing the retail strategy, first as Deputy and then from 2010 as Head of the Retail Business sector. In 2015 he was appointed Head Strategic Projects Galenica Group and since then has had special responsibility for overall management of the preparations for the division of the Group.
